福玛拉诺(英语:Fumarranol)是一种有机化合物,分子式C16H24O4,最初作为抗血管新生药物开发[1],后来发现对N-末端甲硫氨酸METAP2有抑制作用,可能用于治疗疟疾[2][3]

福玛拉诺
识别信息
  • (1S,5S)-5-(hydroxymethyl)-1-methoxy-6-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]bicyclo[3.1.0]hexan-2-one
CAS号912569-37-0
PubChem CID
化学信息
化学式C16H24O4
摩尔质量280.36 g·mol−1
3D模型(JSmol英语JSmol
  • CC(=CC[C@@H]1[C@@](O1)(C)C2[C@]3([C@@]2(C(=O)CC3)OC)CO)C
  • InChI=1S/C16H24O4/c1-10(2)5-6-12-14(3,20-12)13-15(9-17)8-7-11(18)16(13,15)19-4/h5,12-13,17H,6-9H2,1-4H3/t12-,13?,14+,15-,16+/m1/s1
  • Key:CANZHCRPLGNWCR-LMINUHAASA-N

参考文献

编辑
  1. ^ Lu J, Chong CR, Hu X, Liu JO. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. Journal of Medicinal Chemistry. September 2006, 49 (19): 5645–8. PMID 16970390. doi:10.1021/jm060559v. 
  2. ^ Chen X, Xie S, Bhat S, Kumar N, Shapiro TA, Liu JO. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chemistry & Biology. February 2009, 16 (2): 193–202. PMID 19246010. doi:10.1016/j.chembiol.2009.01.006. 
  3. ^ Deu E. Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation. The FEBS Journal. August 2017, 284 (16): 2604–2628. PMC 5575534 . PMID 28599096. doi:10.1111/febs.14130. 

外部链接

编辑